Mr. Zayed is a clinical pharmacist who graduated from Cairo University in 1996 and holds the Canadian Pharmacy board.
Mr. Zayed holds as well MBA in Customer Relation Management in Pharmaceutical at KMBS & He successfully completed a General Management Program at Harvard Business School, Boston MA in 2017.
Mr.Zayed has led a very successful career in the Pharmaceutical arena in the Middle East, he progressively moved in his professional career from a sales head of Biologics in Kuwait then moving to head sales across all the GCC countries and thereafter he was appointed as a regional sales head of all The Middle East including Egypt market to move eventually as the head of Rare disease Franchise of Biologics across the MENA region.
Dr. Majbour is a member of the Royal College of Physician in the UK since 2013 and a member of the Canadian Society of Respiratory Therapists since 2017.
He was the cofounder, and in charge, of the clinic of the Chronic disease in primary health care in Kuwait.He built an extensive clinical experience in internal medicine during his practice in Mubarak Al Kabeer Hospital in Kuwait.
Dr. Talal had also worked as a Researcher in the Ottawa Heart Institute, Medical Device Department for 6 months.
Mr. El Roubi has more than 24 years of experience in the Pharmaceutical Business. worked with Novartis for 7 years as Senior Product Specialist, Regional Sales Manager for Kuwait, Qatar and Oman and was responsible for sales of all lines of Algorithm Sal Biologix FZCO from 2007 till 2019 namely; Neurology, Hematology/Oncology, Rare Disease, General Line, Cardiovascular Line.
Mr. El Roubi is a clinical pharmacists who graduated from Cairo university in 1996.
A senior medical executive with over 24 years of proven track record in both international (Middle East ,Europe & North America) and the Canadian Pharmaceutical industry driving strategic medical leadership across various therapeutic areas mainly in Diabetes, Cardio-metabolic, Hematology, CNS, oncology, nephrology, and immunology.
Demonstrates resourceful managerial skills while providing executive medical leadership to develop effective operational medical strategies. Profound technical knowledge in therapeutics, strategic marketing planning, team-building, project management, Medico Regulatory Governance finance and P&L management.
With 25+ years of extensive experience in pharmaceutical industry Mohamed worked for Multinational and Regional Pharma company in Middle East, Africa and Central Eastern Europe.
Responsible for many geographical and therapeutic areas, he helped these Organizations to be well placed in first seats in term of helping patients, branding, reputation and growth where he oversees sales, marketing, financial planning, risk management, and strategic alliances. With over 30 years of experience in Leadership positions, Mohamed has been instrumental in driving the company’s growth and profitability.
He holds Clinical pharmacy and MBA degrees.
We introduce a range of products that address many indications in the dermatology scope.
We proudly introduce a range of products that relieve different types of Allergies.
We proudly introduce a range of products that relieve different types of pain.
We proudly introduce a strong range of pharmaceutical products in the Anti Infective scope.
We proudly introduce a strong range of pharmaceutical products in the Cardiovascular scope.
We introduce a range of products that address many indications in the dermatology scope.
We introduce a range of products that help patients with disorders of Ears, Nose, and Throat.
We proudly introduce a strong range of pharmaceutical products in the Erectile dysfunction scope.
We proudly introduce a strong range of pharmaceutical products in the gastrointestinal tract scope.
We introduce a range of Medical Devices that give our patients a better quality of life.
We proudly introduce a strong range of pharmaceutical products in the Oncology scope.
We proudly introduce a strong range of pharmaceutical products in the Pediatric scope.
We proudly introduce a strong range of pharmaceutical products in the Rare Diseases scope.